Product Information

METHYLERGONOVINE 0.2 MG TABLET is a generic product labeled by Granules Pharmaceuticals Inc., priced at $5.0733 per EA under NDC 70010078628. Its NADAC has been published 151 times since Dec 27, 2023.

FDA first approved this application on May 15, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

METHYLERGONOVINE 0.2 MG TABLET

Methylergonovine Maleate
$5.0733per EA

Strength

.2 mg/1

NDC

70010078628

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

METHYLERGONOVINE MALEATE

Approval Type

Generic (ANDA)

FDA Application

ANDA210424

FDA Approved

5/15/2018

TE Code

AB

On Market Since

5/25/2018

Pharmacological Classes

Price Statistics

The NADAC for METHYLERGONOVINE 0.2 MG TABLET has been published 151 times since Dec 27, 2023, and over the history we have for it it has declined 65.2%. The table below summarizes its recorded NADAC range and movement.

Current price$5.0733 per EA
All-time high$14.5746 (Jan 10, 2024)
All-time low$4.3506 (Aug 19, 2026)
52-week high$5.7474
52-week low$4.3506
Median price$5.9855
Average price$6.3999
Largest weekly change-34.7% (Feb 21, 2024)
Weeks tracked151
Tracking sinceDec 27, 2023

Price History

1W

0.0%

1M

+12.8%

3M

+14.4%

6M

-8.0%

1Y

+0.8%

3Y

N/A

5Y

N/A

All

-65.2%

Generic Alternatives

The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of METHYLERGONOVINE 0.2 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for METHYLERGONOVINE 0.2 MG TABLET, manufactured by Granules Pharmaceuticals Inc., is $5.0733 per EA (NDC 70010078628), effective Nov 11, 2026.

How has the price of METHYLERGONOVINE 0.2 MG TABLET changed over time?

Over the history we have for it, the NADAC for METHYLERGONOVINE 0.2 MG TABLET has declined 65.2%. It has been tracked across 151 weekly CMS publications since Dec 27, 2023.

What are the highest and lowest recorded NADAC prices for METHYLERGONOVINE 0.2 MG TABLET?

Since Dec 27, 2023, the NADAC for METHYLERGONOVINE 0.2 MG TABLET has ranged from a low of $4.3506 (Aug 19, 2026) to a high of $14.5746 (Jan 10, 2024), with a median of $5.9855 per EA.

Are there cheaper alternatives to METHYLERGONOVINE 0.2 MG TABLET?

5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as METHYLERGONOVINE 0.2 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures METHYLERGONOVINE 0.2 MG TABLET?

METHYLERGONOVINE 0.2 MG TABLET (NDC 70010078628) is labeled by Granules Pharmaceuticals Inc., and CMS classifies it as a generic product.